In conclusion, although the risk of genital infection may increase, SGLT2-i plus metformin may provide an attractive treatment option to those T2DM patients who are unable to achieve glycemic control with metformin alone, on account of its effects on glycemic control, reducing body weight and lowering blood pressure. Here, SLC5A2 is linked to type 2 diabetes mellitus.